Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the sale, the director now owns 131,513 shares in the company, valued at approximately $6,926,789.71. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Trupanion Trading Up 3.2 %
TRUP stock opened at $50.49 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.63 and a current ratio of 1.66. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The business has a fifty day moving average price of $47.39 and a 200-day moving average price of $37.21.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The business had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. Trupanion’s revenue was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.10) EPS. On average, equities research analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current year.
Hedge Funds Weigh In On Trupanion
Analysts Set New Price Targets
A number of analysts have recently commented on TRUP shares. Bank of America boosted their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Piper Sandler boosted their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Stifel Nicolaus raised their price target on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. William Blair initiated coverage on shares of Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Finally, Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $44.67.
Get Our Latest Stock Analysis on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Why Invest in 5G? How to Invest in 5G Stocks
- MarketBeat Week in Review – 11/4 – 11/8
- The How And Why of Investing in Oil Stocks
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.